Drug Trial Radar · NCT07085468
A Study of LY3549492 in Healthy Weight Adult Participants
Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Jul 21, 2025
Primary completion
Aug 14, 2025
Study completion Aug 14, 2025
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jul 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in adult participants with a healthy body max index (BMI) of 22 to 25 kilograms per square meter (kg/m2). Participation in the study will last about 13 months.
Conditions
- Healthy
Interventions
LY3549492Drug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With One or More Serious Adverse Events (SAE) Considered by the Investigator to be Related to Study Drug AdministrationTime frame: Baseline through Week 48
Locations
21 sites in 2 countries. Site status is shown where the registry gives one.
Headlands Research - Scottsdale
Scottsdale, Arizona
Valley Clinical Trials, Inc.
Covina, California
Valley Clinical Trials, Inc.
Northridge, California
Peninsula Research Associates
Rolling Hills Estates, California
Artemis Institute for Clinical Research
San Diego, California
JEM Research Institute
Atlantis, Florida
Clinical Research Atlanta
Stockbridge, Georgia
Great Lakes Clinical Trials - Andersonville
Chicago, Illinois
Alliance for Multispecialty Research, LLC
Lexington, Kentucky
Alliance for Multispecialty Research, LLC
Norman, Oklahoma
Trial Management Associates
Myrtle Beach, South Carolina
Viacar Recherche Clinique
Greenfield Park, Canada
Apex Trials
Guelph, Canada
OCT Research ULC
Kelowna, Canada
Clinique Mémoire de Montréal
Montreal, Canada
Ottawa Memory Clinic
Ottawa, Canada
Richmond Clinical Trials
Richmond, Canada
Q&T Research Sherbrooke Inc.
Sherbrooke, Canada
Toronto Memory Program
Toronto, Canada
BioPharma Services
Toronto, Canada
Diex Recherche Trois-Rivieres
Trois-Rivières, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.